东宝生物（300239）19日在深交所互动易平台上向投资者表示，公司骨胶原蛋白产品的保健食品批文申请工作目前已完成前期工作，已由行政审批部门正式受理，进入审批阶段，相关工作进展顺利。 东宝生物主...
Dongbao biological (300239) 19 in the Shenzhen stock exchange interactions on the platform to investors that the company bone collagen products, health food for work has been completed the preliminary work, from administrative examination and approval departments formally accepted, entered the approval phase, related work in progress smooth. Dongbao biological master...
